Psychotic Disorders are a group of mental disorders characterised by significant disturbances in reality testing, in which a person may experience hallucinations, delusions, disorganised thinking or markedly disorganised behaviour. Psychosis is a syndrome rather than a single diagnosis and can occur in schizophrenia, schizoaffective disorder, certain mood disorders, substance-induced conditions, neurological illnesses and other medical states.
Hallucinations are perceptions occurring without an external stimulus, most commonly auditory hallucinations, whereas delusions are strongly held beliefs that are not adequately explained by the available evidence or the person's cultural context. Disorganised thought can become apparent through speech that is difficult to follow, unusual associations or loss of coherent goal-directed communication. Negative symptoms, including reduced emotional expression, diminished motivation, social withdrawal and reduced speech or spontaneous activity, are particularly important in schizophrenia-spectrum disorders and differ conceptually from psychotic symptoms such as hallucinations and delusions.
Psychotic Disorders encompass several clinically distinct conditions. Schizophrenia generally involves persistent psychotic symptoms together with functional impairment and characteristic disturbances in thought, perception, behaviour and motivation. Schizophreniform disorder has a similar symptom profile but a shorter duration, while brief psychotic disorder involves a psychotic episode of relatively short duration followed by substantial recovery. Schizoaffective disorder combines significant mood episodes with periods of psychosis occurring independently of prominent mood symptoms.
Delusional disorder is characterised primarily by persistent delusions, while functioning outside the domain affected by the delusion can sometimes remain relatively preserved. Psychotic symptoms can also occur in bipolar disorder and severe depressive episodes, in which case their relationship to mood episodes is diagnostically important. These distinctions matter because prognosis, treatment and diagnostic formulation depend on the pattern, duration and context of symptoms rather than on the presence of psychosis alone.
Psychosis can arise through diverse biological, psychological and environmental mechanisms, and no single mechanism explains all cases. Research implicates interactions among genetic susceptibility, brain development, neurotransmitter systems, immune and stress-related processes, sleep disruption and environmental exposures. Dopamine signalling, particularly altered salience attribution and dopaminergic activity in certain neural pathways, has been central to influential models of psychosis, although schizophrenia cannot be reduced to a simple dopamine abnormality.
Genetic risk is highly polygenic, meaning that many genetic variants can each contribute small effects rather than one gene determining the disorder. Environmental associations include childhood adversity, social stress, urbanicity, migration-related factors and exposure to certain psychoactive substances, particularly cannabis in susceptible individuals. These associations describe risk relationships rather than deterministic causes, and many people exposed to individual risk factors never develop a psychotic disorder.
Assessment requires establishing what the person is experiencing, when symptoms began, how they developed and how they affect functioning and safety. Clinicians assess hallucinations, delusions, thought disorder, negative symptoms, mood symptoms, cognition, substance use, medication exposure, sleep, medical history and social circumstances. Differential diagnosis is particularly important because psychosis can result from intoxication or withdrawal, neurological disease, endocrine or metabolic abnormalities, infection, autoimmune conditions, medication effects and severe sleep deprivation.
New-onset psychosis therefore commonly warrants medical assessment rather than an assumption that a primary psychiatric disorder is responsible. Clinicians also assess risks associated with self-neglect, suicidal behaviour, aggression, vulnerability, exploitation and inability to maintain basic needs. Diagnosis is based primarily on clinical assessment, with laboratory tests and imaging used to investigate alternative or contributing causes rather than to provide a single definitive laboratory test for schizophrenia.
Treatment generally combines antipsychotic medication with psychological, social and rehabilitative interventions. Antipsychotics primarily reduce positive psychotic symptoms, although response varies and negative and cognitive symptoms can be more difficult to treat. First-generation antipsychotics tend to produce more extrapyramidal adverse effects, while second-generation agents differ considerably in their metabolic, neurological and other adverse-effect profiles. Clozapine has a distinctive role in treatment-resistant schizophrenia and can substantially reduce persistent symptoms for appropriately selected patients, but requires monitoring because of potentially serious adverse effects.
Psychological interventions can include cognitive behavioural approaches for psychosis, family interventions and structured psychoeducation, while supported employment, social rehabilitation and coordinated community care can address functional consequences. Treatment planning should consider the person's preferences, previous response, adverse effects, physical health, adherence difficulties and social circumstances rather than relying solely on symptom reduction.
Acute psychosis may require urgent intervention when there is substantial risk, severe behavioural disturbance, inability to care for basic needs or a medical condition requiring immediate treatment. Inpatient care can provide a controlled environment for assessment, stabilisation and treatment when community management is unsafe or impractical. De-escalation, therapeutic communication and least-restrictive approaches are important, while restrictive interventions are subject to legal and clinical safeguards that vary by jurisdiction.
Long-term management focuses not only on preventing relapse but also on improving functioning, relationships, housing, education, employment and physical health. Cardiometabolic disease, smoking, sedentary behaviour and medication adverse effects contribute to the increased physical-health burden experienced by some people with chronic psychotic disorders. Early intervention services aim to identify and treat first-episode psychosis promptly because prolonged untreated psychosis is associated with poorer functional outcomes, although individual trajectories vary considerably.
Psychotic Disorders have historically been interpreted through changing medical, social and cultural frameworks. Earlier concepts grouped many forms of severe mental disturbance under broad categories such as insanity, while twentieth-century psychiatry progressively developed more specific diagnostic classifications. Modern classification systems distinguish psychotic syndromes by symptom pattern, duration, functional impact and relationship to mood or substances.
Cultural context is essential because unusual beliefs or experiences must be interpreted within the person's cultural and religious framework; a belief shared and accepted within a community is not automatically a delusion. Likewise, hallucination-like experiences can occur in bereavement, sleep transitions and other circumstances without necessarily indicating a psychotic disorder. The term psychosis should therefore not be used as a synonym for violence, unpredictability or dangerousness: most people experiencing psychosis are not violent, and stigma can itself create barriers to diagnosis, treatment and social participation.
Prognosis varies substantially according to diagnosis, age at onset, symptom pattern, comorbid conditions, treatment response, social support and other factors. Some individuals experience a single episode with substantial recovery, while others develop recurrent or persistent illness requiring long-term treatment. Relapse prevention commonly involves recognising early warning signs, maintaining effective treatment where appropriate, addressing substance use and ensuring continuity of care. Recovery is broader than the disappearance of every symptom and may involve achieving personally meaningful goals despite residual symptoms.
Important misconceptions include assuming that psychosis always means schizophrenia, that hallucinations are invariably auditory, or that delusions can be corrected simply through factual argument. Psychotic Disorders therefore require careful diagnostic differentiation, attention to medical and substance-related causes, evidence-based treatment, physical-health monitoring, safeguarding and respect for autonomy.
